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Abstract
Background: Plants, fungi, bacteria and the apicomplexan parasite Plasmodium falciparum are able to synthesize vitamin B6
de novo, whereas mammals depend upon the uptake of this essential nutrient from their diet. The active form of vitamin B6
is pyridoxal 5-phosphate (PLP). For its synthesis two enzymes, Pdx1 and Pdx2, act together, forming a multimeric complex
consisting of 12 Pdx1 and 12 Pdx2 protomers.
Methodology/Principal Findings: Here we report amino acid residues responsible for stabilization of the structural and
enzymatic integrity of the plasmodial PLP synthase, identified by using distinct mutational analysis and biochemical
approaches. Residues R85, H88 and E91 (RHE) are located at the Pdx1:Pdx1 interface and play an important role in Pdx1
complex assembly. Mutation of these residues to alanine impedes both Pdx1 activity and Pdx2 binding. Furthermore,
changing D26, K83 and K151 (DKK), amino acids from the active site of Pdx1, to alanine obstructs not only enzyme activity
but also formation of the complex. In contrast to the monomeric appearance of the RHE mutant, alteration of the DKK
residues results in a hexameric assembly, and does not affect Pdx2 binding or its activity. While the modelled position of
K151 is distal to the Pdx1:Pdx1 interface, it affects the assembly of hexameric Pdx1 into a functional dodecamer, which is
crucial for PLP synthesis.
Conclusions/Significance: Taken together, our data suggest that the assembly of a functional Pdx1:Pdx2 complex follows a
defined pathway and that inhibition of this assembly results in an inactive holoenzyme.
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Introduction
The active form of vitamin B6 is pyridoxal 5-phosphate (PLP),
which is an essential cofactor for more than 100 enzymes and
thereby involved in catalytic reactions such as amino acid
decarboxylation, elimination and amino-transfer [1]. PLP is
synthesized de novo by plants, almost all bacteria and fungi; however,
mammals depend entirely on the uptake of this indispensable
nutrient from their diet. As shown for yeast, the non-phosphorylated
inactive cofactor is imported via specific transporters and finally
trapped within the cell by phosphorylation catalyzed by pyridoxal
kinase (PdxK) [2,3]. Thus, the dual provision of PLP by de novo
synthesis and salvage indicates necessity and importance of this
cofactor for the survival of yeast and other organisms.
Currently two different pathways for the biosynthesis of PLP are
known. The E. coli- (DOXP-dependent) creates from the substrates
4-phosphohydroxy-L-threonine, 1-deoxyxylulose 5-phosphate
(DOXP) and glutamate pyridoxine. In contrast the fungi-like-
(DOXP-independent) pathway, which has been firstly described in
the fungus Cercospora nicotianae, synthesises the active cofactor PLP
from ribose 5-phosphate, glyceraldehyde 3-phosphate and gluta-
mine by an enzyme complex consisting of two proteins - Pdx1 and
Pdx2 [4–11]. The Pdx2 protein exhibits glutaminase activity and
delivers ammonia to Pdx1 [5,6] (Fig. 1). The crystal structures of
Pdx1 (YaaD or PdxS), and Pdx2 (YaaE or PdxT) from various
organisms have been analyzed [12–14]. Only recently the
structures of the B6 biosynthesis complex (PLP synthase) from T.
maritima and B. subtilis have been solved. Pdx1 assembles into a
dodecamer, consisting of two hexameric crowns, each decorated
by six Pdx2 molecules [15,16].
Here we report on biochemical analyses of the interaction of the
plasmodial Pdx1:Pdx1 interfaces as well as about effects on Pdx2
binding and catalysis. In contrast to the static nature of the Pdx1
crystal structures, this study allows functional insights into the
behaviour of the highly dynamic plasmodial complex and suggests
a possible path for its assembly. The amino acids that are crucial
for the plasmodial PLP complex should be further exploited for the
design of specific drugs which will be restricted to the malaria
parasite and not harming the human host.
Malaria is one of the most serious infectious diseases in the
world (WHO, Communicable Disease Report). Antimalarial drugs
are losing more and more efficacy against the deadliest agent,
PLoS ONE | www.plosone.org 1 March 2008 | Volume 3 | Issue 3 | e1815Plasmodium falciparum. Since a vaccine is not available, an urgent
need exists to identify novel targets for the development of new
chemotherapeutics [17].
Results
Specific activity and mutagenic analyses of the active
sites of Pdx1 and Pdx2
The specific activity of the plasmodial vitamin B6 biosynthesis
complex consisting of PfPdx1 and PfPdx2 (1:1 ratio) was
determined to be 662654 pmol min
21 mg
21 protein if ribose 5-
phosphate, glyceraldehyde 3-phosphate and glutamine were used
as substrates. This is about seven-fold higher than the specific
activity previously observed for the plasmodial enzymes by
Gengenbacher et al. [14] and might result from a different
expression system and purification methods. In the presence of
ammonium chloride instead of glutamine, the plasmodial Pdx1
protein alone revealed a specific activity of 746676 pmol
min
21 mg
21 protein. Because of the observed similar activity,
analyses on the amino acid residues from the PfPdx1 active site as
well as for the Pdx1:Pdx1 interface were carried out by the latter
enzyme assay without PfPdx2.
Structural analysis of Pdx1 (PdxS) from Geobacillus stearothermo-
philus suggested a participation of residues D24, K81 and K149 in
the binding of ribulose 5-phosphate or catalysis [13]. Subsequently
the amino acids K149 from B. subtilis and K82 in the PLP synthase
subunit (YaaD) from Thermatoga maritima, respectively, were
observed to be covalently attached to ribulose 5-phosphate
[7,15]. The homologues of these residues in Pdx1 of the
plasmodial enzyme are D26, K83 and K151, respectively
(Fig. 2A). These amino acid residues were substituted by alanine
using site directed mutagenesis and the mutant proteins were
analysed for enzymatic activity (Fig. 3). The PfPdx1 DKK (D26A/
K83A/K151A) triple mutant enzyme as well as each individual
mutant were inactive. The results confirmed that residues D26,
K83 and K151 are important for PfPdx1 activity; however, a
glutaminase assay with the PfPdx2 wild-type enzyme and the
respective PfPdx1 showed that the ability of Pdx2 to hydrolyze
glutamine was not affected with activities in the same range as
previously reported for the wild-type enzymes [6] (Table 1). This
indicates that the PfPdx1 DKK mutant still binds to PfPdx2. To
verify the ability of the PfPdx1 DKK mutant to bind to the C-
terminal 66 HIS-Tag harbouring PfPdx2HIS wild-type protein,
co-purification analyses were performed (Fig. 4A). The results
clearly demonstrate that modification of these active site residues
of PfPdx1 does not affect its ability to interact with PfPdx2.
K151 is crucial for the dodecameric conformation of the
plasmodial Pdx1
The molecular mass of the wild-type PfPdx1 dodecamer is
424612 kDa, as determined by static light scattering (SLS) (Fig. 5).
These data indicate that the wild-type PfPdx1 assembles into a
dodecameric structure (double crown formation), as has been
Figure 1. Reaction scheme of the Pdx1 and Pdx2 proteins. The
PfPdx2 enzyme depends on its interaction with PfPdx1 for glutaminase
activity. The Pdx1 enzyme is responsible for the de novo synthesis of
PLP by utilizing the substrates ribose 5-phosphate, glyceraldehyde 3-
phosphate and ammonia, whereas the latter is provided by deaminat-
ing of glutamine by Pdx2 via substrate channelling to the attached
PfPdx1 protein. The reactions of each enzyme are indicated.
doi:10.1371/journal.pone.0001815.g001
Figure 2. (A) Homology model of one plasmodial Pdx1 monomer showing the analyzed amino acid residues as indicated. (B) The
interface region between two PfPdx1 proteins within the same hexameric ring illustrating the amino acid residues R85, H88 and E91, which are
involved in Pdx1:Pdx1 binding. The model was generated by Swiss-Model [30] and visualised by PyMOL (www.pymol.org).
doi:10.1371/journal.pone.0001815.g002
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Surprisingly, the double crown formation is inhibited in the
PfPdx1 DKK mutant, which falls apart into two separate crowns,
thereby revealing a hexameric structure with molecular mass of
23865 kDa as determined by SLS (Fig. 5). In order to narrow
down which amino acid residues of the PfPdx1 DKK triple mutant
are involved in PfPdx1:PfPdx1 interactions, the three amino acids
were mutated individually and the derived proteins were analysed
by SLS. Mutation of the PfPdx1 D26 and K83, which are
expected to lie within the active site, does not alter the assembly
state of PfPdx1 wild-type protein; however the mutation of PfPdx1
K151 to alanine - as shown for the DKK triple mutant in Figure 5
- destabilizes the PfPdx1 assembly (Table 1). The result indicates
that this amino acid residue, previously suggested to participate in
the formation of the active site of PfPdx1, is also involved in the
formation of the dodecameric structure of Pdx1 in P. falciparum.
Interestingly, addition of 10 mM glutamine (Q) to the buffer
used in size exclusion chromatography, resulted in an approximate
50% shift in the assembly of the hexameric formation of the DKK
mutant towards the dodecameric structure as estimated from the
molecular mass plot obtained by SLS (Fig. 6A). A similar effect was
obtained by the addition of 10 mM glutamic acid (E) as well as
asparagine (N), although to a lesser extent. In contrast alanine (A)
does not affect dodecamer formation.
The amino acid residues E107, E136 and K189 were identified
as being proximal to K151 using a homology model of the
plasmodial Pdx1 protein (Fig. 2A). E107 and E136 were mutated
to alanine and analyzed for their conformation by size exclusion
chromatography and SLS. None of these mutants, including the
double mutation of both glutamic acids, E107 and E136, showed
an effect on dodecamer assembly (data not shown).
Previous crystal structure analyses showed that H116, R131,
E135, R138, R139, K150 and K188 in the T. maritima structure
are located in a phosphate-binding site [15]. All of these amino
acid residues are conserved in the plasmodial Pdx1 protein at the
positions H117, R132, E136, R139, R140, K151 and K189
(Fig. 3). Mutating the amino acid residues E136, R139 and R140
to alanine (ERR) abolishes the enzyme activity of PfPdx1, implying
the importance of these residues for PLP synthesis. Nevertheless,
the PfPdx1 ERR mutant reveals a molecular mass of 421620 kDa
as measured by SLS, which correlates well with the dodecameric
formation of the wild-type complex. The glutaminase activity of
PfPdx2 is not affected (Table 1), indicating binding of Pdx2 to
Pdx1 as confirmed by co-purification experiments (Fig. 4B).
Figure 3. Alignment of the deduced amino acid sequences of
the YaaD protein from Thermotoga maritima (Tm, AC: Q9WYU4),
the Pdx1 protein from Bacillus subtilis (Bs, AC: NP_387892), the
PdxS protein from Geobacillus stearothermophilus( Gs, AC:
Q5L3Y2) with the Pdx1 protein from P. falciparum (Pf, AC:
XP_966196). The alignment was performed by using CLUSTALW [31].
Identical (*) and similar (:) amino acid residues are indicated below the
protein sequence. Gaps (-) were introduced into the sequence to
maximize homology and to compensate for the different chain lengths.
Mutated amino acid residues, which are predicted to be participating
within the active site and the additional phosphate binding site, are
labelled above by (+) and (1), respectively. The exchanged amino acid
residues, proposed to be involved in the Pdx1:Pdx1 interaction, are
labelled above the sequence by (#).
doi:10.1371/journal.pone.0001815.g003
Table 1. Properties of P. falciparum mutated Pdx1 and Pdx2 proteins in comparison to the wild type.
Mutations in PfPdx1 TmYaaD Pf Pdx1 Pf Pdx2 Oligomerization state of Pf Pdx1 Pdx1:Pdx2 interaction
[mUm g
21] [mU mg
21]
Wild-type (WT) 746676 266619 dodecamer +
D26A 25 n. d. 285630 dodecamer +
K83A 82 n. d. 291622 dodecamer +
K151A 150 n. d. 251616 hexamer +
DKK to AAA (D26/K83/K151) 25, 82, 150 n. d. 274644 hexamer
a +
H88A 87 n. d. 172613 monomer (+)
E91A 90 n. d. 95614 monomer (+)
RHE to AAA (R85/H88/E91) 84, 87, 90 n. d. n. d. monomer -
ERR to AAA (E136/R139/R140) 135, 138, 139 n. d. 28668 dodecamer +
The properties of the recombinant P. falciparum vitamin B6 biosynthesis enzymes Pdx1 and Pdx2 were determined as described in the Material and Methods section.
The results represent the mean values of at least three independent experiments; (TmYaaD) corresponding amino acid residues of YaaD (Pdx1) in T. maritima;( PfPdx1)
PLP formation by PfPdx1 (pmol min
21 mg
21); (PfPdx2) glutaminase activity of PfPdx2 (nmol min
21 mg
21); (+) co-purification of PfPdx1 and PfPdx2 to a lesser extent; n.
d.=not detectable for PLP formation by PfPdx1 (,10 pmol min
21 mg
21).
aapprox. 50% dodecamer in the presence of 10 mM glutamine
doi:10.1371/journal.pone.0001815.t001
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K151 in the assembly of dodecameric Pdx1 does not depend upon
the neighbouring residues in the final assembled structure, rather
that its interaction partners during the assembly must be distal
from its final position, possibly even on adjacent monomers of the
dodecamer.
Analysis of the interaction of Pdx1 monomers in P.
falciparum
As already mentioned, biochemical analyses of the plasmodial
PLP synthase revealed a 1:1 ratio of both Pdx1 and Pdx2 proteins
[6,14]. The crystal structures of the PLP synthase of T. maritima
and B. subtilis demonstrate that the dodecameric complex of Pdx1
Figure 4. Western blot analysis of the co-purified PfPdx1 and PfPdx2HIS proteins. Cell homogenates of the recombinant expression of the
plasmodial Pdx1 protein and Pdx2HIS protein (66 His-tag instead of a Strep-tag) were mixed and subsequently purified via Strep-tag affinity
chromatography of the PfPdx1 protein. The co-purification was visualized by Western blot analysis using a monoclonal anti-Strep antibody (IBA) and
the HIS-probe-HRP (Pierce) as described in Material and Methods. (A) Co-purification of the PfPdx1 wild-type (3) and the PfPdx1 DKK (D26A, K83A and
K151A) triple mutant protein (4) with the PfPdx2HIS wild-type. As a control the PfPdx1 wild-type (WT) (1) and the PfPdx2HIS (2) single proteins were
purified via Strep-tag affinity chromatography and applied in Western blot analysis. (B) Co-purification of the PfPdx1 ERR (5), PfPdx1 RHE (6) as well as
the PfPdx1 H88A (7) and PfPdx1 E91A (8) mutant proteins with the plasmodial Pdx2HIS wild-type. (Note: The PfPdx1 R85A mutant was not
recombinantly expressible.) (C) The gate-keeper PfPdx2HIS E53Y (9) and PfPdx2HIS R154W (10) mutants were co-purified with the PfPdx1 wild-type
protein via its Strep-tag.
doi:10.1371/journal.pone.0001815.g004
Figure 5. Static light scattering of the plasmodial Pdx1 DKK and RHE mutant proteins in comparison to the wild-type (WT). In order
to analyze the structural conformation of the PfPdx1 proteins, size exclusion chromatography was performed with the PfPdx1 WT (—), PfPdx1 DKK
(----) and the PfPdx1 RHE (……) mutant proteins and the masses measured by static light scattering. The corresponding molecular masses and the
proposed structural assemblies are given below. Aliquots of the three peak fractions were subsequently analysed by SDS-PAGE, which confirmed the
presence of PfPdx1 (data not shown).
doi:10.1371/journal.pone.0001815.g005
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turn have no direct contact to one another and are therefore
interacting only with the respective Pdx1 protein [15,16]. Thus,
the double crown complex depends solely on the interaction of
Pdx1. Through an analysis of the protein sequence of the
plasmodial Pdx1 and the homology model, a number of amino
acids within the PfPdx1:PfPdx1 interface region were identified
(Fig. 2B). These residues include R85, H88 and E91 in P.
falciparum, corresponding to amino acids conserved in other
organisms as indicated in Figures 2A,B and 3. To analyse the
impact of these residues on enzyme activity as well as their
importance for the assembly of the entire complex, they were
mutated to alanine. No PLP synthesis activity of the plasmodial
Pdx1 mutants was obtained; however, the glutaminase activity of
PfPdx2 remained, although it was reduced to approx. 66% and
36% in the presence of the PfPdx1 mutants H88A and E91A,
respectively (Table 1). The reaction catalyzed by PfPdx2
complexed with the PfPdx1 triple mutant RHE did not reveal
any detectable glutaminase activity, indicating that the interaction
of the PfPdx1 monomers might affect PfPdx2 binding. Further-
more, to verify whether the homomeric relations influence the
assembly of PfPdx1 and PfPdx2, co-purification experiments were
performed. The PfPdx1 wild-type protein and mutants as well as
the PfPdx2HIS wild-type protein were heterologously expressed
and the bacterial homogenates were mixed in an approx. 1:1 ratio.
Subsequently, the proteins were purified via affinity chromatog-
raphy using the Strep-tag of the respective PfPdx1 wild-type or
mutant proteins. Western blot analysis clearly demonstrated co-
purification of the wild-type forms, whereas the PfPdx1 mutants
were found to be incompetent in binding PfPdx2 (Fig. 4B). The
oligomeric states of the PfPdx1 RHE, H88A and E91A mutant
proteins were further analyzed by size exclusion chromatography
and SLS. No significant assembly to dodecameric or hexameric
formation was detected in either the absence (Fig. 5/6A) or
presence of glutamine. Therefore, the PfPdx1 RHE triple mutant
impedes formation of the entire complex and exists in solution
only as a monomer. Furthermore, even the single mutants H88A
and E91A led to a monomeric state. The R85A mutant did not
express and no further analysis of this mutant was performed.
Ammonia shuttle from PfPdx2 to PfPdx1
PLP synthesis by PfPdx1 depends on ammonia, which is supplied
bythehydrolysisofglutaminetoglutamateandammoniabyPfPdx2,
the glutaminase attached to PfPdx1 [6,14]. Ammonia is thought to
be transferred to the catalytic site of Pdx1 via a protein channel
[13,15,16]. Analysis of the Pdx2 structure led to the suggestion that
the amino acid residues E53 and R154 are the gate-keepers of the
ammonia translocation to Pdx1 [15]. Exchanging these amino acids
to tyrosine (E53Y) and tryptophan (R154W), respectively, resulted in
the total loss of the PfPdx2 glutaminase activity, while the ability of
PfPdx1 to generate PLP is not affected if ammonium is added as an
ammonia source. These mutations did not influence the ability of
PfPdx2 to form a complex with PfPdx1 as clearly demonstrated by
co-purification experiments (Fig. 4C).
Discussion
Two different vitamin B6 biosynthetic pathways have been
previously described [18,19]. While the DOXP-dependent
pathway, consisting of the Pdx protein family, has been well
characterised [10,11,20,21], the DOXP-independent pathway,
first found in fungi, has only recently been identified [18,19]. The
enzymes involved in the DOXP-independent pathway share
neither sequence similarities nor substrate acceptance with E. coli
Figure 6. (A) Influence of glutamine on the conformation of the PfPdx1 DKK mutant. Static light scattering analysis of the plasmodial Pdx1
DKK protein was performed in the presence of 10 mM glutamine. The proposed structural conformations are given above the peak fractions. (B)
Affect of mutations on Pdx1 interactions between hexamers. Monomers coloured in green and violet belong to the upper hexameric crown and the
monomer coloured in salmon belongs to the lower hexameric crown. Mutations in R85, H88 and E91 of the upper crown affect the conformation of
loop 113–119, which interacts with loop-helix 179–191 in the lower crown. Helix 88–98 interacts directly with Pdx2 (not shown).
doi:10.1371/journal.pone.0001815.g006
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to pyridoxine phosphate, which is subsequently oxidized to PLP by
pyridoxine oxidase. The synthesis of the DOXP-independent
pathway seems to be more efficient since it results directly in the
formation of pyridoxal phosphate, the active form of vitamin B6.
This pathway, originally identified by Ehrenshaft et al. [22] in
Cercospora nicotianae, a plant pathogen, is also found in S. cerevisiae as
well as some archaebacteria, eubacteria, the plant A. thaliana, and
recently in the protozoan parasites P. falciparum and T. gondii
[5,6,9,18,23].
PLP is an essential cofactor for various enzymes many of which
are involved in fundamental metabolic reactions [1]. Deletion of
vitamin B6 biosynthesis enzymes resulted in auxotrophy for this
nutrient in bacterial cells [24] and led to a developmental arrest in
plant embryos [9]. Attempts to disrupt the open reading frame of
the plasmodial pdx1 have failed so far, which might indicate an
indispensability of the gene for the survival of the parasite.
Analyses of the crystal structures of the entire PLP synthase
complex in T. maritima and B. subtilis revealed a dodecameric Pdx1
conformation, which is decorated by twelve Pdx2 proteins [15,16].
Very recently, the interface of Pdx1 and Pdx2 has been described
[16]; however, amino acid residues involved in the interaction of
the Pdx1 subunits to form the double crown remained to be
explored. Therefore, site directed mutagenesis was employed to
modify highly conserved amino acid residues that were suggested
to form a buried charge cluster and might be located in the
Pdx1:Pdx1 interface [13,15]. These highly conserved residues are
R85, H88, E91 and D222 in the plasmodial Pdx1 enzyme.
Substitution of H88 and E91 by alanine as well as the derived
triple mutant RHE (R85A, H88A, E91A) resulted in the loss of
PfPdx1 activity. Interestingly, these mutant proteins were neither
able to form a dodecamer nor to associate with PfPdx2. While
these residues primarily interact within the hexameric crown, they
interact indirectly with the opposing hexamer through loop 113–
119. This loop in turn contacts helix 179–191 of the second
hexamer and may mediate dodecameric formation through this
mechanism (Fig. 6B). The effect of RHE on Pdx1-Pdx2
interactions is less clear. These residues are positioned at the N-
terminus of helix 88–98 and the loop following this helix interacts
directly with Pdx2; thus, it is possible that R85, H88 and E91 are
required indirectly for Pdx1-Pdx2 interactions as well.
In T. maritima the active site of YaaD contains the amino acid
residues D25, K82 and K150 [15]. Mutation of these residues in the
bacterial Pdx1 enzyme impedes PLP synthesis [15,25]. This motif is
also present in the plasmodial Pdx1 protein and mutagenic analyses
of the respective residues (D26A, K83A and K151A) show loss of
Pdx1 activity. However, the mutations have no impact on the
PfPdx1:PfPdx2 binding ability and on the glutaminase activity of
PfPdx2 (Table 1). Interestingly, the PfPdx1 DKK mutation leads to a
split of the dodecamer into two hexamers. In the presence of
glutamine, the destabilizing effect of the DKK triple mutation is
reduced by about 50% suggesting an involvement of glutamine in
the stabilization of the PfPdx1 assembly.
The dissociation of the dodecamer is demonstrated to be a result
of the K151A mutation. Examination of the structural data of the B.
subtilis Pdx1 complex (2NV2; www.pdb.org) demonstrates that the
equivalent residue (K149) orientates such that the terminal amino
group points away from the active site and towards the central cavity
of the assembled Pdx1 dodecamer. Nevertheless, it has been shown
that K149 in the B. subtilis enzyme is involved in ribulose 5-
phosphate binding [7]. K151 in the homologous P. falciparum Pdx1 is
located in neither the Pdx1 nor the Pdx2 interface and consequently
its role in formation of the Pdx1 dodecamer is intriguing. In the
structure of T. maritima YaaD, this residue is pointed towards the
phosphate binding site containing ERR [15]. It has been proposed
thatthissitemarkstheglyceraldehyde3-phosphate bindingsiteoran
alternative ribulose 5-phosphate binding site and that K151
participates in this binding [15]. ERR directly interact with helix
183–191 of the opposing hexameric crown forming extensive
interactions. Interestingly, addition of exogenous amino acids with
similar sizes and/or charge to K151 can mimic the function of this
lysine by partially restoring the dodecameric conformation.
However, this result was observed in vitro and remains for elucidation
whether this effect is of physiological relevance.
The observation that Pdx1 exists as monomers, hexamers and
dodecamers, and that only the hexamers and dodecamers interact
with Pdx2 suggests a possible order of assembly. Hexameric
crowns probably form first, likely mediated by residues R85, H88
and E91. Once a crown has formed, it can bind Pdx2, as
evidenced by the data from our co-purification assays, followed by
the assembly of two crowns to form a dodecameric Pdx1 core.
Alternatively, the dodecameric core could form first, followed by
addition of 12 Pdx2 monomers. These two possibilities are not
easily differentiated and clarification of the exact mechanism will
require additional biochemical and structural studies.
It has been reported that the bacterial YaaD and PdxS proteins
from T. maritima and G. stearothermophilus, respectively, possess an
additional phosphate binding site, which might interact with the
phosphate group of the second substrate, glyceraldehyde 3-
phosphate [13,15]. Modification of the homologous amino acid
residues in P. falciparum, E136, R139 and R140, abolished PfPdx1
activity, which emphasizes the important role for catalysis of these
amino acid residues.
For the generation of the active cofactor PLP, an ammonia
source is required, which is provided by the glutaminase Pdx2 via
substrate channelling [6,14,23]. Structural analysis of the bacterial
YaaD (Pdx1) and YaaE (Pdx2) complexes suggested a putative
ammonia channel [15,16]. The passage of ammonia seems to be
modulated by a gate consisting of E47 and R135 in the T. maritima
enzyme [15]. Mutagenesis of the respective conserved counter-
parts in P. falciparum (E53 and R154) indeed results in the loss of
PfPdx2 activity, suggesting a potential steric interference within the
ammonia tunnel, thereby blocking the transmission of ammonia
towards PfPdx1. Interestingly, despite the proximity of the gate to
PfPdx1, the mutation of these two amino acid residues does not
influence the binding capability of PfPdx2 to PfPdx1.
In conclusion, the results presented here suggest a possible path
through which the plasmodial PLP synthase forms a hierarchical
complex using a defined assembly sequence. Confirmation of the
PLP synthase assembly path will require additional experiments to
probe the dynamic behaviour of assembly. This sequence of events
provides a further opportunity to interfere with the assembly of the
complex and can be exploited for the development of novel
chemotherapeutics to combat malaria.
Materials and Methods
Materials
Restriction enzymes and ligase were purchased from New
England Biolabs, USA. Oligonucleotides were from Operon,
Germany. The cloning vector pASK-IBA3, Strep-Tactin-Sephar-
ose, anhydrotetracycline and desthiobiotin were from IBA (Institut
fu ¨r Bioanalytik, Germany). All other used chemicals were from
Sigma, Germany.
Expression and purification of the PfPdx1 and PfPdx2
E. coli BLR (DE3) (Stratagene, Germany) was transformed with P.
falciparum Pdx1 and Pdx2 previously cloned into the expression
Assembly of the PfPLP Synthase
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overnight in Luria-Bertani medium containing 50 mgm L
21
ampicillin. The bacterial culture was diluted 1:50 and grown at
37uC until the A600 reached 0.5. The expression was initiated with
200 ng mL
21 of anhydrotetracycline and the cells were grown for
4 h at 37uC before being harvested. The cell pellet was resuspended
in 100 mM Tris-HCl, pH 8.0, 150 mM NaCl containing 0.1 mM
phenylmethylsulfonyl fluoride, sonicated, and centrifuged at
50,0006gf o r1h o u ra t4 uC. The recombinant Strep-Tag fusion
protein was purified according to the manufacturer’s recommenda-
tion (IBA). The eluate of the affinity chromatography was analysed
by SDS-PAGE [26]. The concentration of the purified recombinant
protein was determined according to Bradford [27].
Oligonucleotides and site-directed mutagenesis of
PfPdx1 and PfPdx2
Oligonucleotides were designed to replace amino acid residues
in the proposed active site as well as in the interface of Pdx1:Pdx1
(Table 2). The putative active site residues of the Pdx1 domain
(D26, K83 and K151) were mutated to alanine and the putative
amino acid residues involved in ammonia channelling of Pdx2
were substituted by tyrosine and tryptophan (Table 2). 35 ng of the
double-stranded supercoiled expression plasmid PfPdx1-IBA3 or
PfPdx2-IBA3 [6] and 100 ng of mutagenic sense and antisense
primers were used in a 50 mL PCR containing deoxyribonucle-
otides, reaction buffer, and Pfu DNA polymerase as described
previously [28]. The cycling parameters were 95uC for 50 s, 55uC
for 60 s, and 68uC for 9 min for 17 cycles. The linear
amplification product was treated with endonuclease DpnI (New
England Biolabs) for 1 h to eliminate the parental template. A
10 mL aliquot from each PCR was used for the transformation of
competent E. coli XL10GOLD cells (Stratagene). All mutations
were verified by automatic sequencing (AGOWA, Germany).
Finally, one clone of each construct was transformed for the
expression in competent E. coli BLR (DE3) cells. The expressed
proteins were purified as described above.
Enzyme assays
The glutaminase activity of PfPdx2 was assayed in two steps,
according to [5,6], by measuring the formation of glutamate,
which is subsequently converted to 2-oxoglutarate by glutamate
dehydrogenase with acetylpyridine adenine dinucleotide (APAD)
as co-substrate. For activity the enzyme complex consisting of
Pdx1 and Pdx2 is required [6]; therefore, both enzymes were
mixed in an equimolar ratio (total amount 30 mg). The assay was
performed in 50 mM Tris-HCl, pH 8.0 in the presence of 10 mM
glutamine in a total volume of 300 mLa t3 7 uC for 20 min. The
enzymatic reaction was stopped by boiling for 1 min. A 50 mM
Tris-HCl, pH 8.0 buffer containing 1 mM EDTA, 0.5 mM
APAD and 7 units of glutamate dehydrogenase was added to a
final volume of 1 ml and incubated for up to 90 min at 37uC.
Finally, the samples were centrifuged for 1 min at 14,0006g and
the absorbance of the supernatant was determined at a wavelength
of 363 nm. The specific activity was calculated with the molar
extinction coefficient of APADH (reduced form of APAD) of
8900 M
21 cm
21.
Table 2. Oligonucleotides which are used for cloning or site directed mutagenesis of PfPdx1 and PfPdx2. Mutation sites are
underlined and in bold.
Name: Oligonucleotide Sequence (59 R 39)
PfPdx1-D26A-S GCTTAAAGGAGGAGTTATTATGGCTGTAAAAAGTGTAGAACAAGC
PfPdx1-D26A-AS GCTTGTTCTACACTTTTTACAGCCATAATAACTCCTCCTTTAAGC
PfPdx1-K83A2-S GTTTCTATTAATGTTCTTGCTGCTGTTCGTATTGGTCATTTTG
PfPdx1-K83A2-AS CAAAATGACCAATACGAACAGCAGCAAGAACATTAATAGAAAC
PfPdx1-K151A-S GAGCTTCTATGATAAGAACTGCCGGCGAAGCTGGTACAGGTAATATTATAG
PfPdx1-K151A-AS CTATAATATTACCTGTACCAGCTTCGCCGGCAGTTCTTATCATAGAAGCTCC
PfPdx1-R85A-S GTTCTTGCTAAAGTTGCAATTGGTCATTTTGTTGAAG
PfPdx1-R85A-AS CTTCAACAAAATGACCAATTGCAACTTTAGCAAGAAC
PfPdx1-H88A-S CTTGCTAAAGTTCGTATTGGCGCCTTTGTTGAAGCACAAATTTTAG
PfPdx1-H88A-AS CTAAAATTTGTGCTTCAACAAAGGCGCCAATACGAACTTTAGCAAG
PfPdx1-E91A-S GTATTGGTCATTTTGTTGCAGCACAAATTTTAGAAGAGC
PfPdx1-E91A-AS GCTCTTCTAAAATTTGTGCTGCAACAAAATGACCAATAC
PfPdx1-RHE-AAA-S CGTTTCTATTAATGTTCTTGCTAAAGTTGCTATTGGCGCCTTTGTTGCAGCACAAATTTTAGAAGAGCTTAAAATTG
PfPdx1-RHE-AAA-AS CAATTTTAAGCTCTTCTAAAATTTGTGCTGCAACAAAGGCGCCAATAGCAACTTTAGCAAGAACATTAATAGAAACG
PfPdx1-ERR-AAA-S GTATGTGGGTGTACAAATTTAGGCGCCGCTCTAGCAGCAATATCTGAAGGAGCTTCTATG
PfPdx1-ERR-AAA-AS CATAGAAGCTCCTTCAGATATTGCTGCTAGAGCGGCGCCTAAATTTGTACACCCACATAC
PfPdx1-E107A-S GCTTAAAATTGATATGATAGATGAAAGCGCTGTATTAACAATTG
PfPdx1-E107A-AS CAATTGTTAATACAGCGCTTTCATCTATCATATCAATTTTAAGC
PfPdx2-IBA3HIS-AS GCGCGCGGTCTCAGCGCTTTAATGATGATGATGATGATGACCTGAATATTTGTAATTTTTAACC
PfPdx2-E53Y-S GGGCTTGTAATTCCAGGTGGATATTCCACAACTGTACGTCG
PfPdx2-E53Y-AS CGACGTACAGTTGTGGAATATCCACCTGGAATTACAAGCCC
PfPdx2-R154W-S CTTAACAGCGGCCTGCATATGGGCACCTTATATAAGAGAA
PfPdx2-R154W-AS TTCTCTTATATAAGGTGCCCATATGCAGGCCGCTGTTAAG
doi:10.1371/journal.pone.0001815.t002
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required. The reaction was performed in the presence of the
substrates 0.5 mM ribose 5-phosphate, 1 mM glyceraldehyde 3-
phosphate and 10 mM glutamine in a buffer containing 100 mM
Tris-HCl, pH 8.0, and 150 mM NaCl [24]. PLP biosynthesis by
Pdx1 alone was carried out under equivalent conditions; however
glutamine was replaced by 10 mM ammonium salt. The total
volume of 1 mL per reaction was incubated for 30 min at 37uC.
Subsequently, the supernatant was analysed at 414 nm for the
formation of a Schiff base between PLP and the Tris base using a
spectrophotometer [7,8].
Co-purification experiments of PfPdx1 and PfPdx2
The plasmodial proteins were recombinantly expressed as
described above. After sonication and centrifugation, the super-
natants of the respective Pdx1 wild-type or mutant proteins were
combined with the supernatants of the PfPdx2 expression. For co-
purification the Strep-tag encoded by the pASK-IBA3 expression
vector was substituted by a 66 His-tag using a PCR reaction
containing the oligonucleotides PfPdx2-IBA3-S and PfPdx2HIS-
IBA3-AS according to [6]. Subsequently, the mixture of PfPdx1
and PfPdx2HIS was purified via Strep-Tactin affinity chromatog-
raphy as described above. For visualizing the co-purification,
Western blot analyses were performed employing a monoclonal
Strep-tag II antibody (IBA) at a dilution of 1:20000 and a
secondary anti-mouse horseradish peroxidase labelled goat
antibody (BioRad, Germany) at a dilution of 1:20000. The
PfPdx2HIS protein was detected by the HIS-Probe-HRP reagent
(Pierce, USA) at a dilution of 1:5000. The hybridization signals
were visualised on X-ray films (Retina, Germany) using the ECL
plus detection system, according to the manufacturer’s instructions
(GE Healthcare).
Determination of the oligomeric state of PfPdx1
In order to investigate the complex formation of PfPdx1, the
Strep-tagged protein was purified as described above. Subse-
quently 100 mg of the protein were separated by gel filtration on a
Superdex 200 10/30 column (GE Healthcare). The elution buffer
contained 100 mM Tris-HCl, pH 8.0, 150 mM NaCl with and
without 10 mM glutamine, glutamic acid, asparagine or alanine,
respectively. A miniDAWN Tristar (Wyatt Technologies, USA)
was connected immediately downstream of the separation media
and used to collect static light scattering (SLS) data [29]. The SLS
data were analyzed using the package ASTRA, based on the
absorption coefficient for PfPdx1 of 19855 M
21 cm
21 and the
molecular mass of 34.2 kDa.
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